"Construção" de proposta de reforma da lei laboral vai para consulta "definitiva" de parceiros, anuncia ministra

[Luka!]

Express Scripts Inc. added $1.59 or 2.5 percent, to $64 in the premarket session, after J.P. Morgan Securities Inc. analyst Lisa Gill lifted her rating on the pharmacy benefits manager's shares to "Overweight" from "Neutral."

Gill said she expects shares to rise after the Maryland Heights, Mo., company provides anticipated strong 2007 guidance Tuesday. She also said shares are valued attractively after the entire sector declined during the past two months.

"We continue to believe PBM industry fundamentals are the strongest we've seen in recent years, driven by opportunities around generics (mail generics are 2-4 times more profitable for PBMs) and specialty pharmacy (based on the robust pipeline and demand from payors for a solution to manage these costs)," the analyst wrote.

The stock has traded in a 52-week range of $58.79 to $95.